Vor Biopharma Inc
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | |
| – | +355.0% | +564.8% | +137.0% | +76.1% | +38.3% | +1.0% | -18.2% | |
| – | +48.3% | +680.2% | +221.5% | +147.9% | +24.9% | -26.3% | +92.1% | |
| – | -46.9% | +184.0% | +111.3% | +138.0% | – | – | – | |
| – | +130.2% | +2,876.6% | -312.8% | – | – | -99.2% | +204,060.0% | |
| – | +0.0% | +456.3% | -6.4% | +117.3% | -87.4% | -78.6% | +310.9% | |
| – | +0.0% | +456.3% | +2,102.6% | +2.7% | – | +36.4% | -150.4% | |
| – | – | – | – | -97.6% | -126.7% | – | – | |
| – | – | – | – | – | – | – | – | |
| – | +618.3% | +366.3% | +182.2% | -49.7% | -97.5% | +1,717.3% | +843.6% | |
| – | – | +492.9% | +71.4% | -186.1% | – | – | +517.3% | |
| – | – | – | – | – | – | – | – |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.